Image
DG23-0112-Specialties-Diabetes-Hemoglobin-Banner

Diagnosing Diabetes

Summary Display Image
Image
DG23-0112-Specialties-Diabetes-Hemoglobinopathies-US-Images-01

Missing One Diagnosis Is One Too Many

​With a strong predictive value for diabetes complications, HbA1c testing should be done routinely in all people with diabetes at initial assessment and as part of continuing care.

The American Diabetes Association (ADA) recommends using NGSP-certified assays and an A1C goal for adults of ≤6.5% (48 mmol/mol).1

Explore HbA1c Testing Solutions

 

1. American Diabetes Association Professional Practice Committee (2023). 6. Glycemic Targets: Standards of Medical Care in Diabetes-2023. Diabetes Care 46 (Suppl 1), S97-S110.


Why Bio-Rad HPLC

Summary Display Image
Image
Bio-Rad HPLC Gold Standard reward frame graphic

40% of all NGSP-certified labs worldwide trust Bio-Rad HPLC for HbA1c. Discover why Bio-Rad HPLC is the top choice among labs that value clinical accuracy.

Learn more about Why Bio-Rad HPLC

Testing for Hemoglobinopathies

Summary Display Image
Image
DG23-0112-Specialties-Diabetes-Hemoglobinopathies-US-Images-06

Tackling a Global Health Burden

Hemoglobinopathies are the most common severe single-gene disorders worldwide, with over 330,000 affected infants born annually. Although thalassemia and sickle cell disease are among the most common monogenic hemoglobin disorders in the world, disease awareness is still far from acceptable. To learn more, view "Thalassemia and Sickle Cell: Past, Present and Future" webinar, presented by Dr. Michael Angastinioti and Dr. Daniel E. Bauer.

 

View webinar

Educational Resources

Summary Display Image
Image
Test Your Knowledge graphics

Bio-Rad believes in sharing knowledge. We’ve created dedicated resources to help you strengthen your hemoglobinopathy expertise.

In this series of educational case studies, learn how to evaluate hemoglobinopathies and sickle cell cases and expand your knowledge of HPLC chromatograms.

Learn more about Test Your Knowledge